Renocrit Recombinant Human Erythropoietin Injection

About Renocrit Recombinant Human Erythropoietin Injection

Renocrit Recombinant Human Erythropoietin Injection is a clinically advanced therapeutic solution designed to stimulate red blood cell production in patients with anemia associated with chronic kidney disease, chemotherapy, or other medical conditions. Formulated using recombinant DNA technology, Renocrit ensures high purity, potency, and consistent bioactivity.

Key Features & Benefits:

• Stimulates Erythropoiesis: Enhances red blood cell production to improve oxygen transport in the body.

• Safe & Reliable: Produced under strict GMP standards, ensuring consistent quality.

• Effective for Anemia Management: Suitable for anemia due to chronic kidney disease, chemotherapy-induced anemia, and other medical conditions requiring erythropoietin therapy.

• Convenient Dosage: Supplied as an easy-to-administer injection for both hospital and clinical use.

Dosage & Administration:
Administered under medical supervision, dosage varies according to the patients hemoglobin levels and clinical condition.

Storage Conditions:
Store at 28C. Protect from light and do not freeze.

Packaging:
Available in 4000 IU vials, ideal for hospital and clinical use.